JPRN-UMIN000023773尚未招募未知
Efficacy of long-acting muscarinic antagonist for chronic cough - LAMA for chronic cough
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 99years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patietns with closed-angle glaucoma or benign prostatic hypertrophy and patients who are thoght to be inappropriate by research physicians
研究者
相似试验
已完成
不适用
The efficacy and safety of long-acting muscarinic antagonist (LAMA) and long-acting beta2-agonist (LABA) in COPD patients with benign prostatic hyperplasia (BPH)JPRN-UMIN000009357Hamamatsu University School of Medicine30
已完成
不适用
Persistence rate with medical treatment in patients with idiopathic or neurogenic overactive bladderOveractive bladderUrological and Genital DiseasesOther specified disorders of bladderISRCTN13129226Erasmus Medical Center123
招募中
2 期
Comparison of efficacy between long-acting muscarinic antagonist (LAMA) and leukotriene receptor antagonist (LTRA) as step-up treatment in patients with uncontrolled bronchial asthmaBronchial asthmaJPRN-UMIN000022696Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine200
尚未招募
4 期
Evaluate the efficacy and safety of Artesunate-mefloquine (ASMQ) and low dose primaquine to treat uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Champasack province, Lao PDRMalariaACTRN12618001349235Ministry of Health120
已完成
不适用
Anti-Muscarinic Agents Alone and in Combination With a Muscarinic Agonist in Subjects with Overactive Bladder(OAB) SymptomsOveractive BladderJPRN-UMIN000007108Department of Urology, Nihon University Itabashi Hospital18